-
1
-
-
0032572913
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
-
Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA : The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 : 584 590, 1998
-
(1998)
N Engl J Med
, vol.339
, pp. 584-590
-
-
Besarab, A.1
Bolton, W.K.2
Browne, J.K.3
Egrie, J.C.4
Nissenson, A.R.5
Okamoto, D.M.6
Schwab, S.J.7
Goodkin, D.A.8
-
2
-
-
0037317068
-
A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients
-
Furuland H, Linde T, Ahlmén J, Christensson A, Strömbom U, Danielson BG : A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplan 18 : 353 361, 2003
-
(2003)
Nephrol Dial Transplan
, vol.18
, pp. 353-361
-
-
Furuland, H.1
Linde, T.2
Ahlmén, J.3
Christensson, A.4
Strömbom, U.5
Danielson, B.G.6
-
3
-
-
27144498003
-
Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease
-
for the Canadian European Study Group:
-
Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D, for the Canadian European Study Group : Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16 : 2180 2189, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2180-2189
-
-
Parfrey, P.S.1
Foley, R.N.2
Wittreich, B.H.3
Sullivan, D.J.4
Zagari, M.J.5
Frei, D.6
-
4
-
-
66449096808
-
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: A randomized trial
-
Foley RN, Curtis BM, Parfrey PS : Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol 4 : 726 733, 2009
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 726-733
-
-
Foley, R.N.1
Curtis, B.M.2
Parfrey, P.S.3
-
5
-
-
33751002326
-
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
-
for the CREATE Investigators:
-
Drüeke TB, Locatelli F, Clyne N, Eckardt K-U, Macdougall IC, Tsakiris D, Burger H-U, Scherhag A, for the CREATE Investigators : Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 : 2071 2084, 2006
-
(2006)
N Engl J Med
, vol.355
, pp. 2071-2084
-
-
Drüeke, T.B.1
Locatelli, F.2
Clyne, N.3
Eckardt, K.-U.4
MacDougall, I.C.5
Tsakiris, D.6
Burger, H.-U.7
Scherhag, A.8
-
6
-
-
33750983605
-
Correction of anemia with epoetin alfa in chronic kidney disease
-
for the CHOIR Investigators:
-
Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, for the CHOIR Investigators : Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 : 2085 2098, 2006
-
(2006)
N Engl J Med
, vol.355
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
Barnhart, H.4
Sapp, S.5
Wolfson, M.6
Reddan, D.7
-
7
-
-
33846669860
-
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: A meta-analysis
-
Phrommintikul A, Haas SJ, Elsik M, Krum H : Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369 : 381 388, 2007
-
(2007)
Lancet
, vol.369
, pp. 381-388
-
-
Phrommintikul, A.1
Haas, S.J.2
Elsik, M.3
Krum, H.4
-
8
-
-
38549092225
-
The normal hematocrit study - Follow-up
-
for the Normal Hematocrit Cardiac Trial Authors
-
Besarab A, Goodkin DA, Nissenson AR, for the Normal Hematocrit Cardiac Trial Authors : The normal hematocrit study - follow-up. N Engl J Med 358 : 433 434, 2008
-
(2008)
N Engl J Med
, vol.358
, pp. 433-434
-
-
Besarab, A.1
Goodkin, D.A.2
Nissenson, A.R.3
-
9
-
-
70350019042
-
Use of erythropoietic stimulating agents in the setting of renal disease
-
Elliott, S.G., Foote, M.A., Molineux, G. (. eds). Basel, Switzerland: Birkhäuser Verlag
-
Goodkin DA : Use of erythropoietic stimulating agents in the setting of renal disease. In : Elliott SG, Foote MA, Molineux G (eds). Erythropoietins, Erythropoietic Factors, and Erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology, 2nd edn. Basel, Switzerland : Birkhäuser Verlag, 2009 : 225 248
-
(2009)
Erythropoietins, Erythropoietic Factors, and Erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology, 2nd Edn.
, pp. 225-248
-
-
Goodkin, D.A.1
-
10
-
-
50849110807
-
Secondary analysis of the CHOIR trial epoetin- dose and achieved hemoglobin outcomes
-
Szczech LA, Barnhart HX, Inrig JK, Reddan DN, Sapp S, Califf RM, Patel UD, Singh AK : Secondary analysis of the CHOIR trial epoetin- dose and achieved hemoglobin outcomes. Kidney Int 74 : 791 798, 2008
-
(2008)
Kidney Int
, vol.74
, pp. 791-798
-
-
Szczech, L.A.1
Barnhart, H.X.2
Inrig, J.K.3
Reddan, D.N.4
Sapp, S.5
Califf, R.M.6
Patel, U.D.7
Singh, A.K.8
-
12
-
-
0344236397
-
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
-
Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW : Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14 : 3270 3277, 2003
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 3270-3277
-
-
Goodkin, D.A.1
Bragg-Gresham, J.L.2
Koenig, K.G.3
Wolfe, R.A.4
Akiba, T.5
Andreucci, V.E.6
Saito, A.7
Rayner, H.C.8
Kurokawa, K.9
Port, F.K.10
Held, P.J.11
Young, E.W.12
-
13
-
-
70350013012
-
-
abstract). Milan, Italy: World Congress of Nephrology Annual Meeting
-
Goodkin DA, Bragg-Gresham JL, Robinson B, Combe C, Fluck R, Mendelssohn D, Akizawa T, Pisoni RL, Port FK : Hemodialysis Patients Who Maintain Higher Hemoglobin Concentration (hgb) without ESA Treatment: Prevalence, Characterization, and Mortality, in the DOPPS (abstract). Milan, Italy : World Congress of Nephrology Annual Meeting, 2009
-
(2009)
Hemodialysis Patients Who Maintain Higher Hemoglobin Concentration (Hgb) Without ESA Treatment: Prevalence, Characterization, and Mortality, in the DOPPS
-
-
Goodkin, D.A.1
Bragg-Gresham, J.L.2
Robinson, B.3
Combe, C.4
Fluck, R.5
Mendelssohn, D.6
Akizawa, T.7
Pisoni, R.L.8
Port, F.K.9
-
14
-
-
66149151415
-
Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States
-
Zhang Y, Thamer M, Cotter D, Kaufman J, Hernán MA : Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States. Clin J Am Soc Nephrol 4 : 638 644, 2009
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 638-644
-
-
Zhang, Y.1
Thamer, M.2
Cotter, D.3
Kaufman, J.4
Hernán, M.A.5
-
15
-
-
49149113180
-
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients
-
Kilpatrick RD, Critchlow CW, Fishbane S, Besarab A, Stehman-Breen C, Krishnan M, Bradbury BD : Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients. Clin J Am Soc Nephrol 3 : 1077 1083, 2008
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1077-1083
-
-
Kilpatrick, R.D.1
Critchlow, C.W.2
Fishbane, S.3
Besarab, A.4
Stehman-Breen, C.5
Krishnan, M.6
Bradbury, B.D.7
-
16
-
-
0034865076
-
Cardiovascular effects of erythropoietin and anemia correction
-
Vaziri ND : Cardiovascular effects of erythropoietin and anemia correction. Curr Opin Nephrol Hypertens 10 : 633 637, 2001
-
(2001)
Curr Opin Nephrol Hypertens
, vol.10
, pp. 633-637
-
-
Vaziri, N.D.1
-
17
-
-
44649121569
-
Thrombosis with erythropoietic stimulating agents - Does iron-deficient erythropoiesis play a role?
-
Dahl NV, Henry DH, Coyne DW : Thrombosis with erythropoietic stimulating agents - does iron-deficient erythropoiesis play a role? Semin Dial 21 : 210 211, 2008
-
(2008)
Semin Dial
, vol.21
, pp. 210-211
-
-
Dahl, N.V.1
Henry, D.H.2
Coyne, D.W.3
-
18
-
-
52049121838
-
Erythropoietin, iron depletion, and relative thrombocytosis: A possible explanation for hemoglobin-survival paradox in hemodialysis
-
Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, Kalantar-Zadeh K : Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis 52 : 727 736, 2008
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 727-736
-
-
Streja, E.1
Kovesdy, C.P.2
Greenland, S.3
Kopple, J.D.4
McAllister, C.J.5
Nissenson, A.R.6
Kalantar-Zadeh, K.7
-
19
-
-
60349120822
-
Intravenous iron versus erythropoiesis-stimulating agents: Friends or foes in treating chronic kidney disease anemia?
-
Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR : Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis 16 : 143 151, 2009
-
(2009)
Adv Chronic Kidney Dis
, vol.16
, pp. 143-151
-
-
Kalantar-Zadeh, K.1
Streja, E.2
Miller, J.E.3
Nissenson, A.R.4
-
20
-
-
0024790160
-
Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a phase III multicenter clinical trial
-
Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR, Korbet S, Krantz SB, Lundin AP, Nissenson AR, Ogden DA, Paganini EP, Rader B, Rutsky EA, Stivelman J, Stone WJ, Teschan P, Van Stone JC, Van Wyck DB, Zuckerman K, Adamson JW : Recombinant human erythropoietin in anemic patients with end-stage renal disease: results of a phase III multicenter clinical trial. Ann Intern Med 111 : 992 1000, 1989
-
(1989)
Ann Intern Med
, vol.111
, pp. 992-1000
-
-
Eschbach, J.W.1
Abdulhadi, M.H.2
Browne, J.K.3
Delano, B.G.4
Downing, M.R.5
Egrie, J.C.6
Evans, R.W.7
Friedman, E.A.8
Graber, S.E.9
Haley, N.R.10
Korbet, S.11
Krantz, S.B.12
Lundin, A.P.13
Nissenson, A.R.14
Ogden, D.A.15
Paganini, E.P.16
Rader, B.17
Rutsky, E.A.18
Stivelman, J.19
Stone, W.J.20
Teschan, P.21
Van Stone, J.C.22
Van Wyck, D.B.23
Zuckerman, K.24
Adamson, J.W.25
more..
-
21
-
-
0031776172
-
Effects of epoetin alfa on hemostasis in chronic renal failure
-
Tang WW, Stead RA, Goodkin DA : Effects of epoetin alfa on hemostasis in chronic renal failure. Am J Nephrol 18 : 263 273, 1998
-
(1998)
Am J Nephrol
, vol.18
, pp. 263-273
-
-
Tang, W.W.1
Stead, R.A.2
Goodkin, D.A.3
-
22
-
-
1942506496
-
Prospective study of the immune effects of normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin
-
Roman RMB, Lobo PI, Taylor RP, Goodkin DA, LaBrecque J, Powers KL, Bolton WK : Prospective study of the immune effects of normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin. J Am Soc Nephrol 15 : 1339 1346, 2004
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 1339-1346
-
-
Roman, R.M.B.1
Lobo, P.I.2
Taylor, R.P.3
Goodkin, D.A.4
Labrecque, J.5
Powers, K.L.6
Bolton, W.K.7
-
23
-
-
44649160130
-
From anemia trials to clinical practice: Understanding the risks and benefits when setting goals for therapy
-
Coyne DW : From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy. Semin Dial 21 : 212 216, 2008
-
(2008)
Semin Dial
, vol.21
, pp. 212-216
-
-
Coyne, D.W.1
-
24
-
-
0036690660
-
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population
-
Dodd RY, Notari EP, Stramer SL : Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42 : 975 979, 2002
-
(2002)
Transfusion
, vol.42
, pp. 975-979
-
-
Dodd, R.Y.1
Notari, E.P.2
Stramer, S.L.3
-
26
-
-
29744451951
-
Transfusion safety: Where are we today?
-
Luban NLC : Transfusion safety: where are we today? Ann NY Acad Sci 1054 : 325 341, 2005
-
(2005)
Ann NY Acad Sci
, vol.1054
, pp. 325-341
-
-
Luban, N.L.C.1
-
27
-
-
54749102410
-
Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients
-
Kuo K-L, Hung S-C, Wei Y-H, Tarng D-C : Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 19 : 1817 1826, 2008
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1817-1826
-
-
Kuo, K.-L.1
Hung, S.-C.2
Wei, Y.-H.3
Tarng, D.-C.4
-
28
-
-
13644269314
-
Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: Immediate and long-term significance
-
Paraskevaidis IA, Iliodromitis EK, Vlahakos D, Tsiapras DP, Nikolaidis A, Marathias A, Michalis A, Kremastinos DT : Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance. Eur Heart J 26 : 263 270, 2005
-
(2005)
Eur Heart J
, vol.26
, pp. 263-270
-
-
Paraskevaidis, I.A.1
Iliodromitis, E.K.2
Vlahakos, D.3
Tsiapras, D.P.4
Nikolaidis, A.5
Marathias, A.6
Michalis, A.7
Kremastinos, D.T.8
-
29
-
-
33644824809
-
Time-dependent associations between iron and mortality in hemodialysis patients
-
Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG : Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 16 : 3070 3080, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 3070-3080
-
-
Kalantar-Zadeh, K.1
Regidor, D.L.2
McAllister, C.J.3
Michael, B.4
Warnock, D.G.5
-
30
-
-
33947212276
-
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study
-
the DRIVE Study Group
-
Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR, the DRIVE Study Group : Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol 18 : 975 984, 2007
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 975-984
-
-
Coyne, D.W.1
Kapoian, T.2
Suki, W.3
Singh, A.K.4
Moran, J.E.5
Dahl, N.V.6
Rizkala, A.R.7
-
31
-
-
85047696910
-
Correction of anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients
-
Sundal E, Kaeser U : Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients. Nephrol Dial Transplant 4 : 979 987, 1989
-
(1989)
Nephrol Dial Transplant
, vol.4
, pp. 979-987
-
-
Sundal, E.1
Kaeser, U.2
-
32
-
-
66849138375
-
Arterial hypertension induced by erythropoietin and erythropoiesis- stimulating agents (ESA)
-
Krapf R, Hulter HN : Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol 4 : 470 480, 2009
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 470-480
-
-
Krapf, R.1
Hulter, H.N.2
-
33
-
-
59149097688
-
Erythropoiesis-stimulating agent treatment with full anemia correction: A new perspective
-
Fishbane S : Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective. Kidney Int 75 : 358 365, 2009
-
(2009)
Kidney Int
, vol.75
, pp. 358-365
-
-
Fishbane, S.1
-
34
-
-
0033920429
-
Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure
-
DOI 10.1081/JDI-100100885
-
Conlon PJ, Kovalik E, Schumm D, Minda S, Schwab SJ : Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure. Ren Fail 22 : 435 444, 2000 (Pubitemid 30441639)
-
(2000)
Renal Failure
, vol.22
, Issue.4
, pp. 435-444
-
-
Conlon, P.J.1
Kovalik, E.2
Schumm, D.3
Minda, S.4
Schwab, S.J.5
-
35
-
-
0034055969
-
Normalization of hematocrit in hemodialysis patients does not affect silent ischemia
-
Conlon PJ, Kovalik E, Schumm D, Minda S, Schwab SJ : Normalization of hematocrit in hemodialysis patients does not affect silent ischemia. Ren Fail 22 : 205 211, 2000
-
(2000)
Ren Fail
, vol.22
, pp. 205-211
-
-
Conlon, P.J.1
Kovalik, E.2
Schumm, D.3
Minda, S.4
Schwab, S.J.5
|